Demystifying the Progression of Retinopathy with Glucagon-Like Peptide-1 Receptor Agonists: Facts, Evidence, and Misperceptions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Demystifying the Progression of Retinopathy with Glucagon-Like Peptide-1 Receptor Agonists: Facts, Evidence, and Misperceptions

Published:2022 Issue:2 Volume:1 Page:53
ISSN:2949-8457
Container-title:International Journal of Diabetes and Technology
language:en
Short-container-title:Int J Diabetes Technol

Author:

Unnikrishnan AG,Kesavadev Jothydev,Sanyal Debmalya,Aneja Pankaj,Saboo BanshiD

Publisher

Medknow

Reference23 articles.

1. Assessing progress in retinopathy outcomes in type 1 diabetes: Comparing findings from the Wisconsin diabetes registry study and the Wisconsin epidemiologic study of diabetic retinopathy;LeCaire;Diabetes Care,2013

2. Diabetic retinopathy: Hyperglycaemia, oxidative stress and beyond;Hammes;Diabetologia,2018

3. Prevalence of diabetic retinopathy in India: All India ophthalmological society diabetic retinopathy eye screening study 2014;Gadkari;Indian J Ophthalmol,2016

4. Impact of the UKPDS – An overview;Home;Diabet Med,2008

5. Glycemic control and prevention of microvascular and macrovascular disease in the Steno 2 study;Vaag;Endocr Pract,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP